US 9132138
Method for the treatment of multiple sclerosis
granted A61KA61K31/385A61K31/565
Quick answer
US patent 9132138 (Method for the treatment of multiple sclerosis) held by CASI Pharmaceuticals, Inc expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CASI Pharmaceuticals, Inc
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/385, A61K31/565, A61K38/215, A61K39/0008